The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Top Cited Papers
- 22 November 2013
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 342 (6161), 971-976
- https://doi.org/10.1126/science.1240537
Abstract
Cyclophosphamide is one of several clinically important cancer drugs whose therapeutic efficacy is due in part to their ability to stimulate antitumor immune responses. Studying mouse models, we demonstrate that cyclophosphamide alters the composition of microbiota in the small intestine and induces the translocation of selected species of Gram-positive bacteria into secondary lymphoid organs. There, these bacteria stimulate the generation of a specific subset of “pathogenic” T helper 17 (pTH17) cells and memory TH1 immune responses. Tumor-bearing mice that were germ-free or that had been treated with antibiotics to kill Gram-positive bacteria showed a reduction in pTH17 responses, and their tumors were resistant to cyclophosphamide. Adoptive transfer of pTH17 cells partially restored the antitumor efficacy of cyclophosphamide. These results suggest that the gut microbiota help shape the anticancer immune response.Keywords
This publication has 43 references indexed in Scilit:
- IRF4 Transcription Factor-Dependent CD11b+ Dendritic Cells in Human and Mouse Control Mucosal IL-17 Cytokine ResponsesImmunity, 2013
- Induction and molecular signature of pathogenic TH17 cellsNature Immunology, 2012
- Peripheral education of the immune system by colonic commensal microbiotaNature, 2011
- Generation of pathogenic TH17 cells in the absence of TGF-β signallingNature, 2010
- Gut-Residing Segmented Filamentous Bacteria Drive Autoimmune Arthritis via T Helper 17 CellsImmunity, 2010
- QIIME allows analysis of high-throughput community sequencing dataNature Methods, 2010
- A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiotaProceedings of the National Academy of Sciences of the United States of America, 2009
- A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responsesNature Medicine, 2009
- Innate immunity and intestinal microbiota in the development of Type 1 diabetesNature, 2008
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007